According to the US president, dozens of US hospitals have ended "this so-called 'gender-affirming care'"

HHS finalized a rule prohibiting Medicaid payments for child gender medicine, including puberty blockers, cross-sex hormones, and surgeries.

El gobierno ha tomado la decisión al concluir que existen «importantes lagunas en la evidencia» que demostraba la seguridad de estos tratamientos